47 results
424B3
CHRS
Coherus Biosciences Inc
26 Jul 23
Prospectus supplement
4:59pm
, as applicable (including each company’s ability to achieve strategic goals, objectives and targets over applicable periods), industry performance
S-4/A
CHRS
Coherus Biosciences Inc
24 Jul 23
Registration of securities issued in business combination transactions (amended)
4:42pm
and uncertainties relating to Coherus’ or Surface’s business, as applicable (including each company’s ability to achieve strategic goals, objectives
S-4
CHRS
Coherus Biosciences Inc
7 Jul 23
Registration of securities issued in business combination transactions
5:03pm
to achieve strategic goals, objectives and targets over applicable periods), industry performance, general business and economic conditions.
The COVID-19
425
3detpn6budaiv4v33cj
16 Jun 23
Business combination disclosure
5:17pm
425
0uze y1505
16 Jun 23
Business combination disclosure
5:16pm
425
5t2w2fxl
16 Jun 23
Business combination disclosure
5:14pm
425
45gpb4usp 5143o1
16 Jun 23
Business combination disclosure
5:14pm
425
fhbw47h212f9q8ih7qp
16 Jun 23
Business combination disclosure
5:12pm
425
4gu6h500mra64 x5
16 Jun 23
Business combination disclosure
5:11pm
425
68s2u4xxznqwubm cdj
16 Jun 23
Business combination disclosure
8:08am
425
ixc3z1849h
16 Jun 23
Business combination disclosure
7:09am
8-K
52j u2j16m2h
16 Jun 23
Coherus to Acquire Surface Oncology
7:06am
8-K
EX-99.1
uchiiv2
16 Jun 23
Coherus to Acquire Surface Oncology
7:06am
8-K
EX-99.1
116ehhlbzp26f4 gwz
8 Nov 21
Coherus BioSciences Reports Third Quarter 2021 Results
4:06pm